Diagnostic Imaging Devices - Estonia

  • Estonia
  • The Diagnostic Imaging Devices market market in Estonia is anticipated to witness impressive growth, with projected revenue of US$24.76m in 2024.
  • This growth is expected to continue at a steady pace, with an annual growth rate (CAGR 2024-2029) of 5.14%.
  • By 2029, the market volume is estimated to reach US$31.81m.
  • When compared globally, it is noteworthy that the United States is expected to generate the highest revenue in the Diagnostic Imaging Devices market market, with an estimated revenue of US$11,930.00m in 2024.
  • Estonia's Diagnostic Imaging Devices market is rapidly growing, driven by the country's commitment to advanced healthcare technology and digital innovation.

Key regions: Germany, Japan, Netherlands, Spain, United States

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diagnostic Imaging Devices market in Estonia has been experiencing steady growth in recent years.

Customer preferences:
Customers in Estonia are increasingly demanding advanced and high-quality diagnostic imaging devices. They value accuracy, speed, and reliability in the diagnosis process, and are willing to invest in state-of-the-art imaging technology. Additionally, there is a growing preference for non-invasive imaging techniques that minimize patient discomfort and reduce the need for invasive procedures.

Trends in the market:
One of the key trends in the Diagnostic Imaging Devices market in Estonia is the increasing adoption of digital imaging technology. Digital imaging offers several advantages over traditional film-based imaging, including faster image acquisition, enhanced image quality, and easier storage and sharing of images. This trend is driven by the need for more efficient and streamlined healthcare processes, as well as the growing availability of digital imaging solutions in the market. Another trend in the market is the rising demand for portable and handheld imaging devices. These devices enable healthcare professionals to perform imaging procedures at the point of care, reducing the need for patients to travel to imaging centers or hospitals. This trend is particularly relevant in rural areas where access to healthcare facilities may be limited. Portable imaging devices also offer cost savings and increased convenience for healthcare providers.

Local special circumstances:
Estonia has a well-developed healthcare system with a strong focus on preventive care and early diagnosis. The government has implemented various initiatives to promote the use of diagnostic imaging devices in order to improve healthcare outcomes and reduce healthcare costs. This includes investments in infrastructure, training programs for healthcare professionals, and reimbursement policies that encourage the use of advanced imaging techniques.

Underlying macroeconomic factors:
Estonia has a stable economy with a high level of digitalization and technological advancement. This provides a favorable environment for the growth of the Diagnostic Imaging Devices market, as healthcare providers have the financial means and technological infrastructure to invest in advanced imaging solutions. Additionally, the aging population in Estonia is driving the demand for diagnostic imaging devices, as older individuals are more likely to require medical imaging for the diagnosis and monitoring of various health conditions. In conclusion, the Diagnostic Imaging Devices market in Estonia is experiencing growth due to customer preferences for advanced and high-quality imaging devices, the adoption of digital imaging technology, and the rising demand for portable and handheld devices. The local special circumstances, including the focus on preventive care and early diagnosis, and the underlying macroeconomic factors, such as the stable economy and aging population, further contribute to the development of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)